Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
MR/K002449/1
Medical Research Council - United Kingdom
MR/K002449/2
Medical Research Council - United Kingdom
PubMed
32561497
PubMed Central
PMC7297686
DOI
10.1016/j.jaip.2020.06.001
PII: S2213-2198(20)30599-7
Knihovny.cz E-zdroje
- Klíčová slova
- Adherence, Asthma, COVID-19, Children, Control, SARS-CoV2, Virus,
- MeSH
- adherence k farmakoterapii MeSH
- Betacoronavirus MeSH
- bronchiální astma epidemiologie patofyziologie terapie MeSH
- časové faktory MeSH
- celosvětové zdraví MeSH
- COVID-19 MeSH
- dítě MeSH
- koronavirové infekce epidemiologie MeSH
- lidé MeSH
- pandemie MeSH
- SARS-CoV-2 MeSH
- schůzky a rozvrhy MeSH
- stupeň závažnosti nemoci MeSH
- telemedicína organizace a řízení statistika a číselné údaje MeSH
- virová pneumonie epidemiologie MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: It is unclear whether asthma may affect susceptibility or severity of coronavirus disease 2019 (COVID-19) in children and how pediatric asthma services worldwide have responded to the pandemic. OBJECTIVE: To describe the impact of the COVID-19 pandemic on pediatric asthma services and on disease burden in their patients. METHODS: An online survey was sent to members of the Pediatric Asthma in Real Life think tank and the World Allergy Organization Pediatric Asthma Committee. It included questions on service provision, disease burden, and the clinical course of confirmed cases of COVID-19 infection among children with asthma. RESULTS: Ninety-one respondents, caring for an estimated population of more than 133,000 children with asthma, completed the survey. COVID-19 significantly impacted pediatric asthma services: 39% ceased physical appointments, 47% stopped accepting new patients, and 75% limited patients' visits. Consultations were almost halved to a median of 20 (interquartile range, 10-25) patients per week. Virtual clinics and helplines were launched in most centers. Better than expected disease control was reported in 20% (10%-40%) of patients, whereas control was negatively affected in only 10% (7.5%-12.5%). Adherence also appeared to increase. Only 15 confirmed cases of COVID-19 were reported among the population; the estimated incidence is not apparently different from the reports of general pediatric cohorts. CONCLUSIONS: Children with asthma do not appear to be disproportionately affected by COVID-19. Outcomes may even have improved, possibly through increased adherence and/or reduced exposures. Clinical services have rapidly responded to the pandemic by limiting and replacing physical appointments with virtual encounters.
Allergy and Clinical Immunology Transylvania University Brasov Romania
Allergy Center CUF Descobertas Hospital Lisbon Portugal
Allergy Department Bambino Gesù Children's Hospital Rome Italy
Children's Center Bethel EvKB University Bielefeld Bielefeld Germany
Children's Hospital Boston Pediatric Allergy and Immunology Boston Mass
Department of Allergy and Immunology Penn State University State College Pa
Department of Allergy Helsinki University Central Hospital Helsinki Finland
Department of Internal Medicine Asthma and Allergy Medical University of Lodz Lodz Poland
Department of Internal Medicine Rush Medical College Chicago Ill
Department of Paediatrics Imperial College London London United Kingdom
Department of Pediatrics Faculty of Medicine The Chinese University of Hong Kong Sha Tin Hong Kong
Division of Pediatrics School of Medicine Pontificia Universidad Catolica de Chile Santiago Chile
Family Physician Airways Group of Canada Edmonton AB Canada
Paediatric Allergy Centre for Allergy Research Karolinska Institutet Solna Sweden
Pediatric Allergy and Asthma Unit Hacettepe University School of Medicine Ankara Turkey
Pediatric Allergy and Immunology Unit Children's Hospital Ain Shams University Cairo Egypt
Pediatric Pulmonology and Allergy Department Hôpital Jeanne de Flandre Lille France
Pediatric Pulmonology and Allergy Unit Children's Hospital la Fe Valencia Spain
Pediatric Pulmonology Division Hospital Moinhos de Vento Porto Alegre Brazil
Pulmonology Department Children's Hospital Zhejiang University School of Medicine Zhejiang China
VN Allergy and Asthma Research Centre Chennai Tamilnadu India
Zobrazit více v PubMed
Cook D.J., Marshall J.C., Fowler R.A. Critical illness in patients with COVID-19: mounting an effective clinical and research response. JAMA. 2020;323:1559–1560. PubMed
Du W., Yu J., Wang H., Zhang X., Zhang S., Li Q., et al. Clinical characteristics of COVID-19 in children compared with adults in Shandong Province, China. Infection. 2020;48:445–452. PubMed PMC
CDC COVID-19 Response Team Coronavirus disease 2019 in children—United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:422–426. PubMed PMC
Tagarro A., Epalza C., Santos M., Sanz-Santaeufemia F.J., Otheo E., Moraleda C., et al. Screening and severity of coronavirus disease 2019 (COVID-19) in children in Madrid, Spain [published online ahead of print April 8, 2020]. JAMA Pediatr. PubMed DOI PMC
Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72-314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–1242. PubMed
Papadopoulos N.G., Čustović A., Cabana M.D., Dell S.D., Deschildre A., Hedlin G., et al. Pediatric asthma: an unmet need for more effective, focused treatments. Pediatr Allergy Immunol. 2019;30:7–16. PubMed PMC
Selby A., Munro A., Grimshaw K.E., Cornelius V., Keil T., Grabenhenrich L., et al. Prevalence estimates and risk factors for early childhood wheeze across Europe: the EuroPrevall birth cohort. Thorax. 2018;73:1049–1061. PubMed
Li X., Xu S., Yu M., Wang K., Tao Y., Zhou Y., et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146:110–118. PubMed PMC
Yamaya M., Nishimura H., Deng X., Sugawara M., Watanabe O., Nomura K., et al. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Respir Investig. 2020;58:155–168. PubMed PMC
Lu X., Zhang L., Du H., Zhang J., Li Y.Y., Qu J., et al. Chinese pediatric novel SARS-CoV-2 infection in children. Coronavirus Study Team. N Engl J Med. 2020;382:1663–1665. PubMed PMC
Liu W., Zhang Q., Chen J., Xiang R., Song H., Shu S., et al. Detection of Covid-19 in children in early January 2020 in Wuhan, China. N Engl J Med. 2020;382:1370–1371. PubMed PMC
Stower H. Clinical and epidemiological characteristics of children with COVID-19. Nat Med. 2020;26:465. PubMed
Levin M., Morais-Almeida M., Ansotegui I.J., Bernstein J., Chang Y.S., Chikhladze M., et al. Acute asthma management during SARS-CoV2-pandemic 2020. World Allergy Organ J. 2020;13:100125. PubMed PMC
Dayal D. We urgently need guidelines for managing COVID-19 in children with comorbidities. Acta Paediatr. 2020;109:1497–1498. PubMed PMC
Mathioudakis A.G., Custovic A., Deschildre A., Ducharme F.M., Kalaayci O., Murray C., et al. Research priorities in pediatric asthma: results of a global survey of multiple stakeholder groups by the Pediatric Asthma in Real Life (PeARL) think tank. J Allergy Clin Immunol Pract. 2020;8:1953–1960.e9. PubMed
Iramain R., Castro-Rodriguez J.A., Jara A., Cardozo L., Bogado N., Morinigo R., et al. Salbutamol and ipratropium by inhaler is superior to nebulizer in children with severe acute asthma exacerbation: randomized clinical trial. Pediatr Pulmonol. 2019;54:372–377. PubMed
Hollander J.E., Carr B.G. Virtually perfect? Telemedicine for Covid-19. N Engl J Med. 2020;382:1679–1681. PubMed
Shaker M.S., Oppenheimer J., Grayson M., Stukus D., Hartog N., Hsieh E.W.Y., et al. COVID-19: pandemic contingency planning for the allergy and immunology clinic. J Allergy Clin Immunol Pract. 2020;8:1477–1488.e5. PubMed PMC
Russell B., Moss C., Rigg A., Van Hemelrijck M. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting? Ecancermedicalscience. 2020;14:1023. PubMed PMC
Niespodziana K., Borochova K., Pazderova P., Schlederer T., Astafyeva N., Baranovskaya T., et al. Toward personalization of asthma treatment according to trigger factors. J Allergy Clin Immunol. 2020;145:1529–1534. PubMed PMC
Eguiluz-Gracia I., Mathioudakis A.G., Bartel S., Vijverberg S.J.H., Fuertes E., Comberiati P., et al. The need for clean air: the way air pollution and climate change affect allergic rhinitis and asthma [published online ahead of print January 9, 2020]. Allergy. PubMed DOI
Worldometer. Coronavirus update (live) https://www.worldometers.info/coronavirus/ Available from: Accessed May 20, 2020.
Korean Society of Infectious Diseases, Korean Society of Pediatric Infectious Diseases, Korean Society of Epidemiology, Korean Society for Antimicrobial Therapy, Korean Society for Healthcare-associated Infection Control and Prevention, Korea Centers for Disease Control and Prevention Report on the epidemiological features of coronavirus disease 2019 (COVID-19) outbreak in the Republic of Korea from January 19 to March 2, 2020. J Korean Med Sci. 2020;35:e112. PubMed PMC
Dong Y., Mo X., Hu Y., Qi X., Jiang F., Jiang Z., et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145:e20200702. PubMed
Guibas G.V., Tsolia M., Christodoulou I., Stripeli F., Sakkou Z., Papadopoulos N.G. Distinction between rhinovirus-induced acute asthma and asthma-augmented influenza infection. Clin Exp Allergy. 2018;48:536–543. PubMed
Jackson D.J., Busse W.W., Bacharier L.B., Kattan M., O’Connor G.T., Wood R.A., et al. Association of respiratory allergy, asthma and expression of the SARS-CoV-2 receptor, ACE2. J Allergy Clin Immunol. 2020;146:203–206. PubMed PMC